Real-time enrollment status for this locally advanced or metastatic solid tumors clinical trial
Current Status
Recruiting
Checked: August 30, 2026 at 9:04 AM UTC
| NCT Number | NCT07066657 |
| Recruiting Status | Recruiting |
| Condition | Locally Advanced or Metastatic Solid Tumors |
| Phase | PHASE1 |
| Target Enrollment | 572 participants |
| Active Locations | 10 sites in the US |
| Sponsor | ArriVent BioPharma, Inc. |
| Last Updated on CT.gov | August 13, 2026 (2 weeks ago) |
As of August 30, 2026: Clinical trial NCT07066657 is currently recruiting participants. This phase1 study for locally advanced or metastatic solid tumors is actively seeking new participants at 10 locations across the United States. The study is sponsored by ArriVent BioPharma, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07066657 is actively recruiting participants as of August 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07066657 was last updated 2 weeks ago (August 13, 2026). HelloStudys verifies this status automatically.